Evidence map›Paper›PMID 29241041›Full record

ArticleCell host & microbe2017

Inhibiting the Plasmodium eIF2α Kinase PK4 Prevents Artemisinin-Induced Latency.

Min Zhang, Julio Gallego-Delgado, Cristina Fernandez-Arias, Norman C Waters, Ana Rodriguez, Moriya Tsuji, Ronald C Wek, Victor Nussenzweig, William J Sullivan

Open access · bronzeAbstract read
In one paragraph

Article in Cell host & microbe, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 1 pooled it
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 1 synthesis or guideline pooled it, 129 citations in OpenAlex.

  1. Ubiquitin-proteasome system inFrontiers in medicine · 2024
    Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Artemisinin-resistant malaria.Clinical microbiology reviews · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Min ZhangDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Pathology, New York University School of Medicine, New York, NY, USA; HIV and Malaria Vaccine Program, Aaron Diamond AIDS Research Center, Affiliate of The Rockefeller University, New York, NY, USA. Electronic address: zhanmin@iu.edu.
Julio Gallego-DelgadoDivision of Parasitology, Department of Microbiology, New York University School of Medicine, New York, NY, USA.
Cristina Fernandez-AriasHIV and Malaria Vaccine Program, Aaron Diamond AIDS Research Center, Affiliate of The Rockefeller University, New York, NY, USA.
Norman C WatersMilitary Malaria Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
Ana RodriguezDivision of Parasitology, Department of Microbiology, New York University School of Medicine, New York, NY, USA.
Moriya TsujiHIV and Malaria Vaccine Program, Aaron Diamond AIDS Research Center, Affiliate of The Rockefeller University, New York, NY, USA.
Ronald C WekDepartment of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA.
Victor NussenzweigDepartment of Pathology, New York University School of Medicine, New York, NY, USA.
William J SullivanDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, USA. Electronic address: wjsulliv@iu.edu.
New York University · USIndiana University – Purdue University Indianapolis · USAaron Diamond AIDS Research Center · USIndiana University School of MedicineRockefeller University · USWalter Reed Army Institute of Research · US

Funding

CD1d/NKT-binding glycolipids in enhancing the immunogenicity of a malaria vaccineR01AI070258 · NIAID · AARON DIAMOND AIDS RESEARCH CENTER · PI TSUJI, MORIYA · 2012 to 2016
$2.2M
Translational control during stage conversion of Toxoplasma, an opportunistic infection of HIV/AIDSR01AI124723 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI SULLIVAN, WILLIAM J, WEK, RONALD C · 2016 to 2020
$2.0M
CD1d/NKT-binding Glycolipids as an Adjuvant for a T cell-based Malaria VaccineR56AI070258 · NIAID · AARON DIAMOND AIDS RESEARCH CENTER · PI TSUJI, MORIYA · 2008 to 2009
$934k
Solving the Artemisinin Dormancy ConundrumR21AI108592 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI NUSSENZWEIG, VICTOR · 2014 to 2015
$466k
Medical Research Council G0900109Medical Research Council G0900278Medical Research Council MR/K011782/1NIAID NIH HHS R01 AI070258NIAID NIH HHS R01 AI124723NIAID NIH HHS R21 AI108592NIAID NIH HHS R56 AI070258
6 · The paper itself

Abstract

Artemisinin and its derivatives (ARTs) are frontline antimalarial drugs. However, ART monotherapy is associated with a high frequency of recrudescent infection, resulting in treatment failure. A subset of parasites is thought to undergo ART-induced latency, but the mechanisms remain unknown. Here, we report that ART treatment results in phosphorylation of the parasite eukaryotic initiation factor-2α (eIF2α), leading to repression of general translation and latency induction. Enhanced phosphorylated eIF2α correlates with high rates of recrudescence following ART, and inhibiting eIF2α dephosphorylation renders parasites less sensitive to ART treatment. ART-induced eIF2α phosphorylation is mediated by the Plasmodium eIF2α kinase, PK4. Overexpression of a PK4 dominant-negative or pharmacological inhibition of PK4 blocks parasites from entering latency and abolishes recrudescence after ART treatment of infected mice. These results show that translational control underlies ART-induced latency and that interference with this stress response may resolve the clinical problem of recrudescent infection.

Indexed as

AnimalsAntimalarialsArtemisininsEukaryotic Initiation Factor-2MicePhosphorylationPlasmodiumProtein BiosynthesisProtein Processing, Post-TranslationalProtein Serine-Threonine KinasesAntimalarialsartemisininArtemisininsEukaryotic Initiation Factor-2Protein Serine-Threonine KinasesartemisinineIF2αendoplasmic reticulumlatencyPK4Plasmodiumrecrudescenceresistancetranslation

Identifiers

PMID29241041
PMCPMC5869688
OpenAlexW2774947765

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.